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Background: Glycaemic response is an important contributor to glycaemic control and is 
positively associated with the risk of developing diabetic complications. As it is largely 
determined by the type and amount of carbohydrate consumed, manipulating carbohydrate 
intake may have the potential to modify glycaemic response. Current guidelines recommend 
that one quarter of your plate contains starchy carbohydrate foods, one quarter protein based 
foods and the remaining half non-starchy vegetables. It is unsure to what extent altering the 
proportions of starchy foods and non-starchy vegetables within a meal will affect glycaemic 
response. 
Objective: To examine the effect on glycaemic response in non-diabetic people of varying 
the proportions of a starchy carbohydrate food and non-starchy vegetables within a meal. 
Design: Randomised controlled crossover trial 
Methods: Over three separate testing days 74 healthy young adults consumed three test meals 
with varying proportions of starchy carbohydrate foods (30g, 45g, 60g available carbohydrate 
from either pasta or rice) and non-starchy vegetables. A gram for gram substitution of pasta or 
rice for non-starchy vegetables was used so as the total weight of each meal remained the 
same. Participants were randomised to receive either three pasta-based meals or three rice-
based meals. Postprandial glycaemic response was measured by finger prick blood samples 
over a 90-minute period following the consumption of each test meal. 
Results: Glycaemic response, measured by incremental area under the curve (iAUC) glucose, 
and 90-minute blood glucose concentration increased as the proportion of pasta or rice within 
the meal increased and the proportion of non-starchy vegetables decreased (p<0.001 and 
p<0.01, respectively). Mean iAUC for the pasta-based meals with the small (30g available 
carbohydrate) and medium (45g available carbohydrate) amount of carbohydrate was 92.9 
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(43.3) mmol*min/L and 117.6 (SD: 43.3) mmol*min/L, respectively and there was a 
difference between them (p=0.002). iAUC for the pasta-based meal with the large amount of 
carbohydrate (60g available carbohydrate) was 122.2 (55.1) mmol*min/L however there was 
no difference between the medium and large meals (p=0.573). For the rice-based meals mean 
iAUC was 128.6 (78.1) mmol*min/L, 140.1 (77.6) mmol*min/L and 196.9 (82.4) 
mmol*min/L for the small, medium and large meals, respectively. There was no difference in 
iAUC between the medium and small meals (p=0.314) however there was a difference 
between the medium and large meals (p<0.001). Rice-based meals induced 16-46% larger 
glycaemic responses than the pasta-based meals with there being a difference for the small 
and large meals (p=0.048 and p<0.001, respectively) yet no difference for the medium meals 
(p=0.243). 
Conclusion: It is recommended that people follow the current plate model guidelines as the 
meal with the smallest proportion of pasta or rice (30g or quarter of a plate) and the largest 
proportion of non-starchy vegetables (half a plate) induced the greatest attenuation in 
glycaemic response.  
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Diabetes prevalence is rapidly increasing worldwide (1). In 2015 estimated diagnosed cases 
of diabetes in New Zealand was 260,458 people, equating to over 5.8% of the population (2). 
The majority of these cases are type 2 diabetes mellitus (T2DM), a disease with modifiable 
lifestyle risk factors (1). The prevention and management of diabetes has therefore been 
identified as a priority health goal (1, 3, 4).  
Controlling glycaemic response is an essential aspect of managing T2DM (5). This is due to 
postprandial hyperglycaemia being a significant risk factor for both macro- and micro-
vascular complications (6-13) and diabetes related mortality (7, 8, 14, 15). As both the type 
and amount of carbohydrate are positively related to postprandial glycaemic response (16), 
there is the potential to influence glycaemic response by manipulating carbohydrate intake.  
Main meals generally consist of three main components, starchy carbohydrate foods, non-
starchy vegetables and protein-based foods. The starchy carbohydrate component of the meal 
largely determines glycaemic response as starchy foods generally contain more available 
carbohydrate (17) and have a higher glycaemic index (GI) (18, 19) than non-starchy 
vegetables. Whilst all health organisations recommend people with and without diabetes 
consume starchy foods, the amounts and proportions they advise vary. The New Zealand 
Ministry of Health advises having more non-starchy vegetables than starchy vegetables on a 
plate (20) and Diabetes New Zealand recommend one quarter of the plate be starchy 
carbohydrate foods, one quarter protein based foods and one half non-starchy vegetables (21). 
The United Kingdom (UK) suggests that meals should be based around starchy foods (22). 
Diabetes associations also recognise that carbohydrate requirements for people with diabetes 
need to be individualised based on body weight, physical activity levels and blood glucose 
control (23-25).  
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It is unclear to what extent altering the proportions of starchy foods and non-starchy 
vegetables within a meal will affect glycaemic response. A decrease in the amount of starchy 
foods tends towards a reduction in glycaemic response, however, some vegetables contain 
starch and sugars (17), therefore a compensatory increase in the amount of vegetables within 
a meal will likely influence glycaemic response. Currently no studies have measured the 
glycaemic effect of substituting starchy foods for non-starchy vegetables within a meal in 
people with or without T2DM. As it has been found that the relative glycaemic response is 
similar between individuals with differing glucose tolerance (26-28), it is likely that results 
obtained from people with normal glucose tolerance will also be applicable to people with 
impaired glucose tolerance and T2DM.  
Therefore, the aim of this study was to examine the effect on glycaemic response in non-
diabetic people of varying the proportions of a starchy carbohydrate food and non-starchy 
vegetables within a meal. These results could then be used to provide further evidence-based 
recommendations for the proportions of starchy and non-starchy foods that people should 
include within their meal. 
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2 Literature Review 
2.1 Introduction 
The purpose of this literature review was to examine the evidence for influencing glycaemic 
response through dietary manipulation.  
Specifically this review focuses on: 
• Providing an overview of glycaemic response and how this is influenced by glycaemic 
index (GI) and glycaemic load (GL).  
• Discussing whether or not glycaemic response is clinically relevant for people with 
normal glucose tolerance, impaired glucose tolerance and type 2 diabetes mellitus 
(T2DM).  
• Identifying strategies using meal components that may reduce glycaemic response and 
improve glycaemic control.  
• Reviewing the current dietary guidelines and recommendations for carbohydrate and 
vegetable intake as well as the proportions of foods you should include on your plate.  
• Recognising the gaps in the current literature around meal composition and glycaemic 
response to develop a rationale for this study.  
Literature was sourced from the following online databases, Medline via Ovid, Pubmed and 
Scopus. Search key words included, ‘postprandial glycaemia’, ‘type 2 diabetes mellitus’, 
‘glycemic index’, ‘glycemic load’, ‘carbohydrate’ and ‘vegetables’. Additional literature was 
identified from the reference lists of relevant articles that were collected. Studies conducted in 
human participants and written in English were considered appropriate to be included in this 
review. 
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2.2 Glycaemic response  
Glycaemic response or postprandial glycaemia is the term used to describe the normal 
physiological response of plasma glucose concentrations after eating a meal (29). Typically 
plasma glucose concentrations begin to rise about ten minutes after starting a meal due to the 
absorption of dietary carbohydrate (29). The quantity, composition and timing of the meal are 
all key contributors to the postprandial glycaemic response (29). For healthy individuals 
glycaemic response generally does not exceed 7.8 mmol/L (140 mg/dl), and preprandial levels 
are restored within 2-3 hours (5) due to the insulin-stimulated uptake of glucose by the liver 
and peripheral tissues (29). However, for people with T2DM, decreased insulin sensitivity 
and secretion (30, 31) results in frequently occurring postprandial hyperglycaemia (32). This 
is defined as a plasma glucose level >7.8 mmol/l (140 mg/dl) 1-2 hours after the ingestion of 
food (International Diabetes Federation 2011).  
Glycaemic response can be measured by collecting a series of fingertip capillary samples, 
typically in 15 to 30 minute time intervals following meal consumption (33). Alternatively, 
continual glucose monitoring systems (CGMS) provide another measure of glycaemic 
response by displaying blood glucose concentrations every few minutes (34). Post-challenge 
glycaemia describes the glycaemic response following an oral glucose tolerance test (OGTT) 
(5) and is often used in the research setting or to confirm a diabetes diagnosis. It is measured 
by collecting a single capillary blood sample two hours after the consumption of a standard 
glucose load (35). 
It has been recognised that not all carbohydrates induce an identical postprandial response and 
instead both the type and quantity of carbohydrate consumed significantly impacts glycaemic 
response (36). To account for these differences, the glycaemic index (GI) concept was 
developed to rank foods based on the glycaemic response following consumption of a fixed 
amount of available carbohydrate (usually 50g) (37, 38). GI is calculated by expressing the 
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measured glycaemic response to a test food as a percentage of the measured glycaemic 
response to a reference food (38), therefore GI is a relative measure of glycaemic response 
(39). However, individuals do not always consume foods in portions containing 50g of 
available carbohydrate, therefore the glycaemic load (GL) concept has been developed (40, 
41). GL is a product of a food’s GI and the total amount of carbohydrate consumed (GL = GI 
x available carbohydrate (g)). Thus, GL has been used as a practical predictor of the 
postprandial glycaemic response (40, 42). 
2.3 Clinical relevance of controlling glycaemic response 
2.3.1 For healthy individuals with normal glucose tolerance 
It is unclear to what extent people with normal glucose tolerance need to be concerned about 
glycaemic response. Blood glucose concentration is under tight homeostatic control and in 
response to a carbohydrate containing meal, the body releases insulin to lower blood glucose 
concentration to the basal value. While there is some evidence that a diet high in total 
carbohydrate or in rice may increase the risk of developing T2DM (43) data are inconsistent, 
as no relationship (44-46) and even a protective effect of high rice or total carbohydrate 
intakes have been reported (47, 48).  
Furthermore, in these studies the associations explored were between food or nutrient intake 
and risk, rather than directly measuring glycaemic response and relating it to risk. Dietary GI 
and GL are the most widely used surrogate markers of glycaemic response, despite 
methodological shortcomings in the collection and estimation of these exposures (49). 
Relationships between dietary GI/GL and T2DM risk have been inconsistent. In several large 
prospective studies, positive associations between GI and/or GL and the incidence of T2DM 
have been found (40, 50-53), whereas no such associations have been found in other studies 
(44, 54, 55).  
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Short-term intervention trials examining the effect of low GI compared to high GI diets on 
intermediate risk factors for T2DM have also produced mixed results. While several studies 
found low GI diets to improve insulin sensitivity and secretion (56-58), others found no such 
effect (59, 60). Many studies were also unable to achieve differences in postprandial glucose 
profiles between treatment groups (61-64) and differing definitions of low GI and high GI 
diets introduced considerable heterogeneity between studies. Due to this inconsistency in 
results, the American Diabetes Association (ADA) have no recommendations for using GI to 
guide carbohydrate intake in order to prevent T2DM (35). It therefore still remains uncertain 
whether there is any clinical relevance in targeting a reduction in glycaemic response for 
healthy individuals. Further well-designed studies are required before evidence-based 
conclusions can be made.  
2.3.2 For individuals with impaired glucose tolerance or T2DM  
In contrast to the conflicting evidence regarding the relationship between glycaemic response 
and the risk of developing T2DM, there is ample evidence supporting the necessity to control 
glycaemic response in people with impaired glucose tolerance or diabetes mellitus (65, 66). 
Glycaemic response contributes to overall glycaemic control, represented by haemoglobin A1C 
(HbA1C)(67). HbA1C reflects the average glucose exposure over the preceding 2-3 month 
period. Healthcare providers regularly measure HbA1C to assess adequacy of patient’s therapy 
and adherence to treatment plans (29, 35). Postprandial glycaemic response was found to be 
as important if not more important than other glycaemic markers for the prediction of HbA1C, 
therefore targeting glycaemic response is an important strategy for HbA1C reduction (67-69).  
A positive association has been identified between glycaemic response and the risk of 
cardiovascular disease (CVD) and diabetes related mortality (6-9). The DECODE study, 
including 22,514 participants from ten European prospective cohort studies found that the 
addition of post-challenge glycaemia data to fasting plasma glucose data significantly 
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improved the prediction of all cause mortality (p=<0.001) and cardiovascular mortality 
(p=<0.005) (14). A positive relationship has also been found between glycaemic response and 
the incidence and progression of diabetic retinopathy in long-term prospective cohort studies 
(11, 12).  
While an association has been identified between glycaemic response and the risk of 
developing diabetic complications, the effectiveness of using treatment specifically targeting 
glycaemic response for improvements in clinical outcomes is unclear (5, 70). The HEART2D 
randomised controlled trial compared the effects of selectively reducing either fasting plasma 
glucose or glycaemic response, using different insulin regimens (71). Participants in the 
glycaemic response targeted group achieved lower daily mean postprandial glycaemic 
response than the basal group, indicating the effectiveness of the intervention (71). However, 
there was no difference in HbA1C and cardiovascular outcomes between the two groups (71). 
Another large and long-term randomised controlled trial in which an insulin release stimulant 
was used, failed to attenuate glycaemic response and therefore no significant benefit on 
cardiovascular outcomes was found (72). 
Acarbose targets glycaemic response by slowing the rate of carbohydrate digestion (73). 
Large and long-term trials in which this has been used have found conflicting results. The UK 
Prospective Diabetes Study randomised 1946 people with T2DM to receive a maximum dose 
of 100mg of acarbose three times per day or a matching placebo for three years. Although 
treatment with acarbose improved HbA1C significantly more than treatment with a placebo, 
there was no difference in the relative risk of micro-vascular disease or any diabetes related 
end point between the two groups (74). In contrast, using the same dosing regimen in 1368 
people with impaired glucose tolerance over a period of three years, the risks of T2DM, CVD 
and hypertension were reduced relative to a placebo control group (75, 76). Analysis of 
several more studies was undertaken in a meta-analysis from which it was concluded that 
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acarbose was more effective than a placebo at reducing the risk of myocardial infarction and 
other cardiovascular events (77). However, in a subsequent meta-analysis it was concluded 
that there was no significant difference in morbidity and mortality between treatment with 
acarbose or a placebo (78). This body of literature therefore suggests that acarbose will likely 
attenuate glycaemic response and despite the evidence being unclear, it may improve clinical 
outcomes. 
The mechanism for the effect of acarbose can be argued as although acarbose is purported to 
work by slowing the rate of carbohydrate absorption, evidence from ileostomy patients 
indicates that it also prevents digestion of up to 44% of carbohydrate intake (79). It is 
therefore uncertain whether any clinical effect of acarbose observed in some of the above 
studies was as a result of a reduction in glycaemic response or a decreased energy utilisation 
leading to weight loss. A study indeed found a significant difference in weight loss favouring 
the acarbose group (77). However, regardless of the mechanism, a reduction in glycaemic 
response by treatment with acarbose may be beneficial for improving clinical outcomes.  
In summary, while further research is needed to confirm whether or not glycaemic response 
should be treated preferentially, it is still an extremely important aspect of achieving optimal 
glycaemic control and therefore managing T2DM and preventing complications. 
2.4 Potential dietary strategies to reduce glycaemic response and improve 
glycaemic control 
Lifestyle interventions targeting diet and physical activity have been found to improve 
glycaemic markers and to delay the progression from impaired glucose tolerance to T2DM 
(80, 81). However, it is not possible to attribute these findings to a reduction in glycaemic 
response as body weight and physical activity levels improved in these interventions as well 
(80, 81). Examining the use of dietary strategies which more specifically target glycaemic 
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response provide greater evidence for ways in which glycaemic response can be manipulated 
to improve glycaemic control. 
2.4.1 Decreasing carbohydrate consumption 
There is a dose response relationship between the amount of carbohydrate consumed and 
glycaemic response (16, 82, 83). Therefore, reducing the amount of carbohydrate in an 
individual’s diet may have the potential to influence overall glycaemic control. However in 
the Canadian Trial of Carbohydrates in Diabetes, 150 people with T2DM were randomised to 
follow diets containing 39%, 47% or 52% carbohydrate for 12 months, and it was found that 
changes in HbA1c were independent of the dietary assignment (84). In another 12 month 
randomised trial, 115 participants with T2DM consumed either a very low carbohydrate diet 
(15% total energy (TE) from carbohydrate (CHO)) or an energy matched higher carbohydrate 
diet (50% TE from CHO) (85). No difference in HbA1C was found between groups, although 
participants on the low carbohydrate diet did have greater reductions in some measures of 
glycaemic variability (85). In a number of intervention studies designed to compare low fat, 
high carbohydrate diets (~50% TE from CHO) to low carbohydrate diets (30-40% TE from 
CHO), no significant difference in HbA1C was again found (86-88).  
In several other intervention studies, low carbohydrate diets have been found to produce 
reductions in HbA1C. A 12 month randomised trial found that in the group of participants with 
T2DM (n=54), HbA1C decreased more in the group following a low carbohydrate diet (33% 
TE from CHO) than in the group following a conventional weight loss diet (50% TE from 
CHO) (89). Another long term study in which 133 participants chose to follow either a 
loosely restricted carbohydrate diet (45% TE from CHO) or a conventional diet (57% TE 
from CHO) for two years also found significantly greater reductions in HbA1C for participants 
following the lower carbohydrate diet (90). Shorter-term intervention studies where 
participants acted as their own control found that a lower carbohydrate diet (10% and 32% TE 
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from CHO) reduced HbA1C significantly more than a higher carbohydrate diet (~40% TE 
from CHO) (91, 92). A meta-analysis also concluded that lower carbohydrate diets reduced 
HbA1C significantly more than a variety of comparison diets (93). 
Several of these studies did however have a number of limitations, including small participant 
numbers, short study durations and high dropout rates (90, 91). Furthermore, the effect of 
weight loss was often not considered, therefore it is uncertain whether the observed results are 
due to a diet lower in carbohydrate or that participants lost more weight (88, 90, 91). 
Considerable heterogeneity between studies included in the meta-analysis, particularly in the 
types of control diets that were used, limit the reliability of the conclusion (93). 
While there is inconsistency in the data, some evidence suggests that following a lower 
carbohydrate diet may improve glycaemic control. Therefore, individuals with T2DM who 
consume large amounts of carbohydrate may benefit from reducing their consumption. This is 
supported by the ADA as they recognise that monitoring the amount of carbohydrate that 
people with T2DM consume is an important strategy for controlling glycaemic response and 
achieving optimal glycaemic control (24). 
2.4.2 Increasing non-starchy vegetable consumption  
Non-starchy vegetables have both a low GI (18, 19, 94) and contain very little carbohydrate 
(17) thus it is likely that they would induce a lower glycaemic response compared to other 
carbohydrate-containing foods. Significant inverse associations between HbA1C and total 
vegetable intake and between HbA1C and green leafy vegetable intake in people with T2DM 
have been found (95, 96). However, inverse relationships were also found between vegetable 
intake and body mass index (BMI) and vegetable intake and consumption of other food 
groups such as nuts, legumes and fish (95). It is therefore unsure how much of the association 
can be attributed to vegetables (95). 
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In an intervention study, 68 overweight people were randomised to follow a high fruit and 
vegetable diet or a healthy reference diet for four months (97). The intervention group 
consumed significantly more vegetables than the reference group however there was no 
difference in HbA1C between the two groups (97). Another study randomised 750 people to a 
low fat, high fibre, high fruit and vegetable diet or to no intervention diet. They found that 
despite the intervention group increasing their consumption of vegetables more than the 
control group, there was no significant difference in serum glucose samples between the two 
groups (98). However a favourable effect of increased vegetable consumption was found in 
another trial that randomised 101 people with T2DM to either consume their vegetables 
before starchy carbohydrate foods or to use food exchange lists that included the energy and 
nutrient content of foods to guide meal planning (99). The vegetables before carbohydrate 
group consumed significantly more green vegetables and less rice than the exchange based 
meal plan group and had a significantly greater reduction in HbA1C (99).  
The effect on glycaemic control of following dietary patterns with high intakes of non-starchy 
vegetables has also been investigated. Long-term randomised controlled trials have provided 
evidence for a beneficial effect of a Mediterranean diet compared to a low fat, higher 
carbohydrate diet or an ADA recommended diet for improvements in glycaemic control (100-
102). One study found that participants following a low fat vegan diet had significantly 
greater reductions in HbA1C compared to those following an ADA recommended diet (103). 
Another study found no significant difference in HbA1C between groups following a 
vegetarian diet or a diabetes recommended diet (104). It is therefore difficult to make any 
conclusions about the effectiveness of vegetarian or vegan diets for glycaemic control. 
Furthermore, any potential glycaemic benefit of these dietary patterns cannot be solely 
attributed to a higher intake of non-starchy vegetables. It is unsure whether other aspects of 
these dietary patterns that have proven health benefits, such as a decreased consumption of 
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saturated fat and an increased consumption of unsaturated fat, may in fact be responsible for 
influencing glycaemic control.  
While there is not a large body of evidence regarding the effects of increasing non-starchy 
vegetable consumption, there is some evidence to suggest that it may improve glycaemic 
control. 
2.4.3 Lowering glycaemic index and glycaemic load 
The GI of a food is calculated from its relative postprandial glycaemic response and GL has 
been found to be positively related to glycaemic response (82, 83, 105). Therefore, in theory 
choosing lower GI and GL foods would cause acute reductions in glycaemic response, with 
these accumulating over a longer period of time to reduce HbA1C. However in practice this 
may be more difficult to achieve. In a six-month intervention study which randomised 210 
people with T2DM to either a low GI (GI=70, GL=129) or a high cereal fibre diet (GI=84, 
GL=166) a significantly greater reduction in HbA1C was found in the low GI group (106). 
Another large three month randomised controlled trial comparing a low GI diet incorporating 
increased legume consumption (GI=66, GL=133) with a high wheat fibre diet (GI=82, 
GL=142) also found HbA1C reductions favoured the low GI group (107).  
In a longer term intervention study no difference in HbA1C was found between people 
following a low GI (GI=55, GL=133), high GI (GI=63, GL=135) or low carbohydrate diet 
(GI=59, GL=110) despite the low GI group having significantly lower 2hr-post OGTT blood 
glucose concentrations than the other two groups (84). A randomised crossover study of 20 
people with T2DM used CGMS to measure the glycaemic impact of a low GI (GI=48, 
GL=109) and high GI diet (GI=61, GL=142) (108). No difference in glycaemic response or 
any other measures of glycaemia between the two diets were found over four consecutive 24-
hour periods (108).  
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It therefore remains unclear whether lowering the GI or GL of a diet will reduce glycaemic 
response and improve glycaemic control in people with T2DM. However as a number of 
studies suggest positive results it is a strategy that may be useful for some individuals.  
2.5 Current dietary guidelines and recommendations  
2.5.1 New Zealand  
Guidelines for carbohydrate intake in New Zealand are based on the Acceptable 
Macronutrient Distribution Range (AMDR) of 45-65% total energy from carbohydrate per 
day (109-111). Practically, both the Ministry of Health guidelines for New Zealand adults and 
the Diabetes New Zealand guidelines recommend at least six servings per day of carbohydrate 
based foods and at least three servings per day of vegetables (20, 21). The diabetes guidelines 
include starchy vegetables in the carbohydrate category whereas the Ministry of Health 
guidelines consider these as vegetables (20, 21). This discrepancy is likely due to starchy 
vegetables containing more carbohydrate than non-starchy vegetables (112). Therefore, if 
consumed in large quantities they have a greater tendency to raise blood glucose 
concentration, which is particularly important for people with diabetes to avoid (112).  
Guidelines for the proportions of foods that a meal should contain include the Ministry of 
Health’s recommendation to have more non-starchy than starchy vegetables on a plate (20). 
Diabetes New Zealand and Vegetables.co.nz advise that meals follow the ‘Healthy Plate 
Model’, where one quarter of the plate are starchy carbohydrate foods, one quarter protein 
foods and the remaining half non-starchy vegetables (21, 113). It therefore appears as though 
there is a consensus in New Zealand that non-starchy vegetables should be the largest 
component of a meal. 
For the quantity of foods to include within a meal, Diabetes New Zealand mentions that 
approximately 3-4 serves of carbohydrate at each main meal is the quantity that most people 
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with diabetes require. As one serve equates to 15g of carbohydrate, this is roughly 45g of 
carbohydrate per main meal (23). However, carbohydrate requirements are individual 
depending on body weight, activity levels and glycaemic control, therefore this amount of 
carbohydrate will not suit everyone (23).  
The focus of both the Ministry of Health and Diabetes New Zealand guidelines is on a healthy 
and well balanced diet (20, 21). Despite recognising that a low carbohydrate diet may work 
for some people if it is carefully managed, Diabetes New Zealand does not promote its use 
(114).  
2.5.2 Worldwide 
Recommendations for carbohydrate intake in Australia, USA and Canada are the same as 
New Zealand, 45-65% total energy from carbohydrate per day (110, 115, 116). The UK 
recommends a population average of around 50% of total energy from carbohydrate per day 
(117). However, based on systematic review evidence, both the ADA and Diabetes UK have 
taken the position that there is no optimal percentage of carbohydrate in the diet that is widely 
applicable to the diabetic population (24, 118, 119). Instead they advise a much more 
individualised approach, based on metabolic status, weight management and glycaemic 
control goals, similar to Diabetes New Zealand (23, 24, 119).  
Practically, Canadian guidelines recommend 7-10 servings of fruit and vegetables and 6-8 
servings of grain products per day (120). Rather than recommending a number of servings, 
the American dietary guidelines advise 2-3 cups of vegetables and 6-8 ounces (170-230g) of 
grains per day (115, 121). The UK Eatwell Guide recommends that both fruit and vegetables 
and starchy foods should each make up just over one third of your diet and similarly to New 
Zealand, you should consume at least 5 portions of fruit and vegetables per day (20, 22). 
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The Canadian Diabetes Association (CDA), ADA and Singaporean Health Promotion Board 
promote a plate model with the same proportions of carbohydrate, protein and non-starchy 
vegetables as the Diabetes New Zealand and vegetables.co.nz plate model (21, 113, 122-124). 
However, the UK Eatwell Guide advises that meals should be based around starchy foods 
(22), indicating that a worldwide consensus on meal proportions has not been formed.  
Diabetes UK, the Diabetes and Nutrition Study Group of the European Association for the 
Study of Diabetes and the CDA recommend low GI and GL diets. They also suggest that 
carbohydrate intakes at the lower end of the recommended range may be an option for some 
people (25, 119, 125). However, they do not support very low carbohydrate diets in order to 
prevent high fat intakes (25, 125). The ADA is of the opinion that there is insufficient 
evidence to recommend following a low GI, GL or carbohydrate diet (24). All of these 
organisations are in agreement that is important for people with T2DM to incorporate 
vegetables into their diet (24, 25, 119, 125). 
2.6 Conclusion and rationale for research 
The prevalence of diabetes, particularly T2DM, is rising both in New Zealand (2) and around 
the world (1). This is largely due to an increase in risk factors, most importantly physical 
inactivity and obesity (1). The World Health Organization has therefore identified diabetes as 
one of the four priority non-communicable diseases and has committed to reducing its burden 
(1, 3, 4). As there is inconsistency in the literature, the relationship between glycaemic 
response and the risk of developing T2DM remains unclear (40, 44, 50-55). However, 
glycaemic response has consistently been recognised as an important contributor to T2DM 
management as it is positively associated with HbA1C (67-69) and diabetes related 
complications (6-9, 11, 12, 14, 88).  
As non-starchy vegetables have a lower GI and contain less available carbohydrate than 
starchy carbohydrate foods (17-19, 94, 126) they have the potential to induce a lower 
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glycaemic response. Despite inconsistency in the data, some evidence does suggest that 
lowering the carbohydrate content of the diet (89-92), increasing vegetable consumption (99) 
and reducing dietary GI and GL (106, 107) may improve glycaemic control in people with 
T2DM. However, no studies have investigated the glycaemic effect of directly substituting 
starchy carbohydrate foods for non-starchy vegetables. Altering the proportion rather than the 
types of foods within a meal may be a strategy that is easier for people with T2DM to 
implement. Therefore, given the current gap in the literature, this study was conducted to 
assess the effectiveness of substituting non-starchy vegetables for starchy carbohydrate foods, 
to reduce glycaemic response and improve glycaemic control.  
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3 Objective Statement 
The aim of this study was to examine the effect on glycaemic response of varying the 
proportions of a starchy carbohydrate food and non-starchy vegetables within a meal. Results 
could then be used to form evidence-based recommendations for the proportions of foods to 
include within a meal for the attenuation of glycaemic response. 
Objective one: To determine whether altering the proportions of a carbohydrate-based food 
and non-starchy vegetables has a significant affect on glycaemic response, as measured by 
incremental area under the blood glucose curve (iAUC). 
Objective two: To compare the effects on glycaemic response of consuming two different 
types of carbohydrate-based foods (pasta or rice) within a meal. 
Objective three: To determine whether altering the proportions of a carbohydrate-based food 
and non-starchy vegetables within a meal will affect blood glucose return to baseline 





This study was a randomised controlled trial conducted at the Department of Human 
Nutrition, University of Otago, Dunedin, New Zealand, during March and April, 2016.  
4.1 Ethics 
The University of Otago Human Ethics Committee granted ethical approval for this study 
(Appendix A, B). Māori consultation from the Ngāi Tahu Research Consultation Committee 
was sought and approved (Appendix C). Prior to recruitment potential participants were 
given a brief presentation outlining the study rationale and participant requirements. A 
participant information sheet was also provided, which reiterated these requirements and 
listed contact details where any concerns or queries could be directed (Appendix D). Written 
consent forms were obtained from all participants before testing commenced (Appendix E). 
This trial was registered with the Australian New Zealand Clinical Trials Registry (trial 
ID:ACTRN12616000716460) (Appendix F). 
4.2 Participants 
4.2.1 Sample size calculation 
It was estimated from previous work (127), that a sample size of 34 participants in both the 
pasta and rice arms of the study would have 90% power to detect a 30% difference in iAUC 
at the alpha 0.05 level. To allow for a 10% dropout we aimed to recruit 38 participants per 
group. A 30% difference was chosen to be clinically relevant as this corresponds to the 
difference in iAUC between a low and high GI food. 
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4.2.2 Recruitment 
Participants were recruited from a convenience sample of University of Otago undergraduate 
human nutrition students in March 2016. They were invited to participate by both email and 
an in class presentation.  
4.2.3 Eligibility criteria 
Participants were required to be between 18 and 60 years of age and without any special 
dietary requirements that were unable to be catered for within the confines of this study. Prior 
to study commencement an email was sent to all participants requesting information on any 
special dietary needs. 
4.3 Study design 
This study was a randomised controlled crossover trial in which participant’s consumed three 
test meals with varying proportions of a starchy food (pasta or rice) and non-starchy 
vegetables. Half of the participants were allocated to receive three pasta-based meals and the 
other half to receive three rice-based meals. Meals were comprised of 30g, 45g and 60g of 
available carbohydrate from either pasta or rice. Within each intervention group participants 
consumed all three meals at separate testing sessions. The meal containing 45g available 
carbohydrate was set as the reference, with 30g and 60g available carbohydrate representing a 
one serve (15g of carbohydrate) (23) difference from this meal. Non-starchy vegetables were 
used as a direct substitution for pasta or rice, therefore the total weight of each meal remained 
the same. A constant portion of mince was also included in the meal. Blood glucose 
concentration was measured for 90 minutes following the consumption of each meal to 
determine glycaemic response. The three different meal proportions (30g, 45g and 60g 
available carbohydrate from pasta or rice) are shown in Figure 4.1. 
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Included in this study, fellow Master of Dietetics candidates and a PhD candidate also 
collected data on speed of eating, energy intake and satiety. Their results will be presented 
separately and are not reported in this thesis. 
   
   
Figure 4.1 Small (30g available carbohydrate), medium (45g available carbohydrate) and 
large (60g available carbohydrate) pasta and rice-based meals 
4.4 Randomisation  
Eighty participants were invited to take part in the study and randomised to receive either 
pasta (n=40) or rice (n=40) based meals. Males were block randomised to ensure equal sex 
distribution between the two groups, controlling for any potential sex variability in glycaemic 
response. Participants were also randomised to the order in which they were to receive the 
three test meals; to three out of the five available testing sessions; and to a start time (11:50 or 
13:00). Figure 4.2 illustrates the different orders of intervention that participants were 
randomised to. There were some changes to these allocations following randomisation as it 
was necessary that gluten free and vegan participants received rice-based meals and a number 
of participants were unavailable on certain test days or at their designated times.  
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Dr Jill Haszard, a biostatistician in the University of Otago, Department of Human Nutrition 
used Stata Statistical Analysis Software (version 13.1, Stata Corporation, Texas) to carry out 











Figure 4.2 Representation of study design and the different orders of intervention that participants were randomised to 
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4.5 Development of the test meals 
4.5.1 Identifying ingredients 
The ingredients were selected with the consideration of developing a meal that was palatable, 
visually appealing, affordable and representative of a meal that the general population would 
regularly consume. Pasta and rice were chosen as the starchy foods due to their similar 
carbohydrate content. This allowed the required amount of available carbohydrate to be 
obtained in equal cooked weights of each food. The type of pasta selected was penne because 
it complemented other meal components well and was easy to consume. Jasmine rice was 
chosen due to its high GI value, therefore providing the largest contrast in GI between the rice 
and pasta (18, 19, 126). Frozen stir-fry vegetables were selected as they included the greatest 
variety of non-starchy vegetables, were of high quality and were easy to prepare. To complete 
the meal it was decided to include a protein portion. Beef mince flavoured with a store bought 
pasta sauce was chosen as it mixed easily with the carbohydrate components and is generally 
well accepted by the participant’s age group. 
4.5.2 Determining the quantity of the meal components 
The reference meal was set at 45g available carbohydrate from pasta or rice in response to 
both Diabetes New Zealand and diabetes dietitian, Zhoushi Zhang’s advice to patients with 
T2DM to follow the healthy plate model (21). This model indicates that one quarter of the 
plate should be starchy foods, which theoretically equates to 45g available carbohydrate in a 
starchy food (21, 23). The 30g, 45g and 60g available carbohydrate in the three meals 
corresponded to 100g, 150g and 200g of either cooked pasta or rice, as outlined in Appendix 
G. The quantity of non-starchy vegetables in the reference meal (45g available carbohydrate 
from a starchy food) was set at 200g as this best represented the healthy plate model’s half a 
plate (21). The amount of cooked mince was kept constant for all test meals at 200g. This 
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quantity was representative of one quarter of a plate, as recommended by the healthy plate 
model (21).  
4.5.3 Special dietary requirements 
Special meals were prepared for participants who were unable to consume the standard meal 
due to special dietary requirements. A mycoprotein based mince alternative was used in place 
of beef mince for participants who were vegetarian (n=6) or participants who required a meal 
that was Halal (n=2). By substituting the mince for chickpeas a meal was created for 
participants who were vegan (n=2). Participants with Irritable Bowel Syndrome (IBS) (n=2) 
received a meal with a pasta sauce and stir fry vegetables that contained no onions.  
4.5.4 Composition of the test meals 
The composition of each test meal is shown in Table 4.1. The standard, vegetarian and IBS 
meals all weighed 550g. The vegan meals had an extra 25g of pasta sauce, as this was 
required for palatability when mixed with the chickpeas, therefore, each of the vegan meals 
weighed 575g. The meals were described as small, medium and large, representing 30g, 45g 
and 60g of available carbohydrate from either pasta or rice respectively. 
Table 4.1 Composition of the test meals1 
Meal type Starchy food Non-starchy 
vegetables 
Mince or mince 
alternative2 
Pasta    
Small  100g pasta 250g 200g  
Medium  150g pasta 200g 200g  
Large  200g pasta 150g 200g  
Rice    
Small  100g rice 250g 200g  
Medium  150g rice 200g  200g  
Large  200g rice 150g 200g  
1. All weights listed as cooked weights 
2. 200g mince was replaced with 100g chickpeas + 125g pasta sauce for the vegan meals  
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4.6 Study procedure 
Testing took place over the lunchtime period at the University of Otago, Department of 
Human Nutrition Undergraduate Laboratory. Five weekly testing sessions were held across a 
seven-week period, allowing for a two-week break when participants were unavailable. 
Participants were required to attend three testing sessions and were allocated an arrival time 
of 11:50 or 13:00. There was a washout period of between one and five weeks depending on 
which sessions participants had been allocated to and not because a washout period of this 
length was necessary.  
Participants were asked to arrive at the laboratory having had nothing to eat or drink (except 
for water) for the previous two and a half hours. This was to ensure their baseline blood 
glucose concentrations were similar across the testing sessions and they did not begin testing 
already in a postprandial state. Participants were also asked to not consume water 30 minutes 
before the session began as a large intake of water immediately prior to testing may have 
limited their ability to consume the entire meal. To reduce variability, participants were 
regularly reminded to keep their timing and type of food and drink consumption as well as 
exercise prior to the session consistent across their three testing days. If they were walking or 
cycling to the laboratory participants were asked to do so slowly, to prevent elevating their 
blood glucose levels. 
A single finger-prick blood sample was taken from participants 5-15 minutes after their 
arrival, allowing time for blood glucose levels to stabilise. This result was used as their 
baseline blood glucose concentration and the time the sample was taken was recorded as time 
‘zero’. Participant’s allocated test meal was then delivered to them and they were instructed to 
begin eating straight away. Blood glucose concentration was measured over the following 90-
minute period with measurements being taken at 15, 30, 45, 60 and 90 minutes after time 
‘zero’. If a participant’s baseline blood glucose concentration was above 6mmol/L they were 
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questioned as to whether they had consumed any food or drink within the required fasting 
period. If they admitted to not having fasted for this period of time they were asked to 
reschedule their testing session (n=1). 
Participants were informed that they were required to consume the entire meal. There was no 
time frame within which they had to finish the meal as their speed of eating was also being 
measured. A single 250ml cup of water was provided for participants to drink during meal 
consumption, with additional water available on request after they had finished the meal. 
Participants were asked to remain seated for the duration of the testing session, with 
exceptions being toilet visits if required.  
A number of measures were used to maintain consistency of procedures: 
• All data were collected over a 7-week period 
• Testing was undertaken on the same day of the week and at the same time for each 
participant   
• The candidate and two members of the research team prepared all test meals 
• Standardised preparation and cooking procedures were used 
• All members of the data collection team were trained in the technique of taking finger 
prick blood samples by a registered nurse  
4.6.1 Measuring blood glucose concentration 
Before blood sample collection began, the participants chosen finger was sanitised using a 
70% isopropyl alcohol swab (Webcol™ Alcohol Prep, Covidien™ Ltd.; United States of 
America). While allowing time for this to dry, the participant’s finger was gently massaged to 
increase blood flow. A 1.8mm disposable lancet (Unistik® 3 Normal, Owen Mumford Ltd; 
England) was then used to prick the finger by firmly pressing down off centre of the fingertip. 
The finger was again gently massaged to form a small drop of blood, with this first drop being 
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wiped off using a non-woven swab (Multisorb®, BSN medical Limited; United Kingdom) 
The finger was further massaged until a larger drop of blood was formed and drawn up by a 
microcuvette (HemoCue®; Sweden). The microcuvette was wiped on a non-woven swab 
(Multisorb®, BSN medical Limited; United Kingdom) to remove any excess blood and then 
immediately placed into the HemoCue® Glucose 201+ Analyser (Aktiebolaget Leo 
Diagnostics, Helsingborg; Sweden) to determine blood glucose concentration. Each morning 
before data collection began, the Hemocue was calibrated using a solid control provided by 
the manufacturer (Appendix H). The result of each blood glucose measurement was recorded 
by both the participant, on an individual recording sheet (Appendix I), and by the trained 
research assistant responsible for obtaining their blood samples (Appendix J).   
4.6.2 Demographic questionnaire 
All participants completed a single demographic questionnaire with information on gender, 
date of birth, ethnicity and smoking status (Appendix K). Questions on ethnicity and 
smoking status were taken from the New Zealand census (128). 
4.6.3 Anthropometric measurements 
Height and weight were recorded (Appendix K) using a single measurement following 
standardised procedures (129). To ensure consistency, one person was responsible for taking 
all participants’ measurements, using the same freestanding calibrated stadiometer (Holtain 
Limited, United Kingdom) and calibrated electronic scales (Seca Alpha, model 770, 
Germany) throughout. Participants were asked to remove their shoes and any excess clothing 
or heavy personal items in their pockets. These data were used to calculate BMI for each 
participant using the equation: weight in kilograms/ height in metres squared (kg/m2). 
4.6.4 Preparation of the test meals 
All meals were prepared in the University of Otago, Department of Human Nutrition, 
metabolic kitchen. Food safety principles were adhered to throughout the entire food 
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preparation process (130). Weights of all meal components were measured using electronic 
kitchen scales (Salter, model 3010, England) to within 3g of the nominated weight. Excluding 
the rice, all meal components were precooked, cooled and appropriately proportioned into 
round foil plates. Meals were then covered in tinfoil and placed in a freezer. Coloured stickers 
were used to label each meal according to the proportions and type of starchy food they 
contained. Special meals were identified by an additional written descriptor. The morning 
prior to each testing day, meals were removed from the freezer and placed into a fridge to 
thaw. On the day of testing a convection oven preheated to 180°C was used to reheat the 
meals for 1 hour and 45 minutes. Before consumption a sub sample of meals were 
temperature tested using a temperature probe to ensure they were above the required 60°C for 
food safety and palatability reasons (130). Fresh rice was cooked each testing day and 
portioned immediately prior to consumption. The methods used to prepare each component of 
the standard meal are further described on the following page. Appendix L outlines the 




A 1:2 ratio by weight of Jasmine rice (Pams®; New Zealand) to water was used. The rice was 
cooked in two rice cookers (Tefal Automatic Rice Cooker, model Serie R07, China) that 
automatically switched to a keep warm mode once the rice was cooked. 
Pasta: 
Dried penne pasta (San Remo, San Remo Macaroni Co Pty Ltd; Australia) was added to 
boiling water and cooked until the pasta was al dente. A ratio of 2.5kg dried pasta: 10L 
boiling water was used. Once cooked, the pasta was strained through a colander and cold 
water was run through it to stop the cooking process. Finally the pasta was tossed with canola 
oil (Sunfield Oils, Tasti Products Ltd, Auckland; New Zealand), 2 tablespoons oil for every 
2.5kg dried pasta.    
Vegetables: 
A 750g portion of vegetables (Asian Stir Fry Vegetables, Watties®, Heinz Watties Ltd, New 
Zealand) was steamed with one-quarter of a cup of water in a microwave for 10 minutes.  
Mince: 
Raw premium beef mince (New World, Dunedin; New Zealand) was cooked in batches in a 
large saucepan with canola oil (Sunfield Oils, Tasti Products Ltd; New Zealand). Once the 
mince was browned a jar of pasta sauce (Extra Bolognaise Pasta Sauce, Dolmio®, Mars Food; 




4.6.5 Calculation of glycaemic index and glycaemic load 
The GIs of meal ingredients were selected from published databases and studies (18, 94, 126). 
A GI of 43 was chosen for the penne pasta (18) and a GI of 115 for the jasmine rice (126). A 
number of the non-starchy vegetables included in the meal, such as cauliflower and broccoli, 
did not have published GI values. It was decided to assign an estimated GI of 31 to the non-
starchy vegetables, as this was the measured GI of carrots in a similar study population (94) 
and it was understood that almost all non-starchy vegetables have a low GI (131). Calculation 
of GI and GL for each meal type and its components is presented in Appendix M. To account 
for the proportion of available carbohydrate (AvailCHO) within the meal that each component 
provided, the following equation was used to calculate meal GI (132): 
Meal GI = {(GIFood A x AvailCHOFood A (g)) + (GIFood B x AvailCHOFood B (g)) +…}  
/AvailCHOMeal (g) 
Meal GI was then used to calculate meal GL using the following equation (40): 
Meal GL = ((Meal GI x AvailCHOMeal (g)) / 100) 
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4.7 Statistical analysis 
Stata Statistical Analysis Software (version 13.1, Stata Corporation, Texas) was used for 
incremental area under the curve (iAUC) analysis. All other data handling and analysis was 
carried out with the statistical programme Microsoft Excel (Microsoft® Excel® for Mac 2011. 
Version 14.1.3. Microsoft Corporation 2011). A P-value of <0.05 was set as statistically 
significant. The nutritional composition of the test meals was calculated using the dietary 
assessment software Kai-culator (version 1.131, Department of Human Nutrition, University 
of Otago, New Zealand). 
In accordance with Brouns et al. the trapezoidal rule was used to calculate incremental area 
under the curve (iAUC), with any area beneath the baseline concentration ignored (42). iAUC 
for each test meal and each participant was calculated individually then averaged according to 
meal type. A mixed effects regression analysis with participants as a random effect was used 
to determine the statistical difference in iAUC between the different meal proportions. To 
analyse the mean difference in iAUC between the pasta-based and rice-based meals a linear 
regression model was used for each meal size. Because the variance of iAUC increased with 
increasing means, data was log-transformed to stabilise the variance.  
Both analyses were adjusted for the order in which participants were randomised to receive 
the intervention. As the distribution of participants who received a special meal was unequal 
between the pasta and rice-based intervention groups, a sensitivity analysis was run for the 
analyses that compared these meals. It was found that after adjustment for special meals this 












































Analysed  (n=37) 
Excluded from analysis (n=0) 
Assessed for eligibility (n=80) 
Excluded  (n=0) 
• All participants met inclusion 
criteria 
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Allocated to rice intervention (n=40) 
• Received allocated intervention (n=37) 
• Did not receive allocated intervention 
(declined to participate) (n=3)  
Lost to follow-up (n=0) 
Discontinued intervention (n=0) 
Allocated to pasta intervention (n=40) 
• Received allocated intervention (n=37) 
• Did not receive allocated intervention  
(Declined to participate) (n=2) 
(Withdrew from the course) (n=1) 
Analysed  (n=37) 






Figure 5.1 CONSORT diagram: participant flow through the study 
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5 Results 
Eighty participants were randomised to either the pasta or rice intervention groups and 74 
participants chose to take part in this study. All data are included in this analysis. Figure 5.1 
shows participant flow through the study. 
5.1 Participant characteristics 
Demographic characteristics of participants are presented in Table 5.1. Participants were 
between 19 and 36 years of age, with 93% under 24 years of age. The study population were 
predominantly female and of New Zealand European ethnicity. Most participants had a BMI 
within the healthy range (18.5 – 24.9kg/m2), with only three participants categorised as obese 
(BMI ≥ 30kg/m2). Just one participant in each intervention group reported that they were a 
current smoker. 
Table 5.1 Demographic characteristics of study participants 
Characteristics Pasta (n=37) Rice (n=37) 
Gender1   
Male 9 (24%) 10 (27%) 
Female 28 (76%) 27 (73%) 
Age (years)2 21.0 (2.4) 21.5 (2.0) 
Ethnicity1   
NZ European 23 (62%) 29 (78%) 
Maori 2 (5%) 2 (5%) 
Pacific Islander 0 (0%) 0 (0%) 
Other 12 (32%) 6 (16%) 
BMI (kg/m2)2 23.4 (4.0) 23.6 (3.5) 
1. Results presented as n (%) 
2. Results presented as mean (SD) 
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5.2 Nutritional composition of the test meals 
The nutritional compositions of the test meals are presented in Table 5.2. All standard meals 
were of equal weight (550g). As the amount of available carbohydrate within the meal 
increased so too did the energy content. There was an inverse relationship between the 
amount of available carbohydrate provided by the pasta or rice and the amount provided by 
the vegetables and pasta sauce. However, the overall available carbohydrate content of the 
meal increased as the proportion of pasta or rice increased. Dietary fibre content decreased as 
the amount of vegetables within the meal decreased, whereas protein and fat content remained 
similar between the meals.  
A positive relationship was observed between an increased proportion of starchy foods and 
both meal GI and GL. There was a greater increase in meal GL than there was in meal GI and 
the estimated GIs and GLs of the rice-based meals were considerably higher than the pasta-
based meals. The nutritional composition of the special meals is presented in Appendix N. 
Table 5.2 Nutritional composition of the standard meals, per meal1 
1. Total cooked weight of all standard meals was 550g 
2. AvailCHO = CHO content – dietary fibre 
  
Meal type Energy 
(kJ) 















& sauce  
Total 
Pasta          
Small  1832 30.0 11.3 41.3 10.5 38.0 10.5 40 17 
Medium  2074 45.0 10.6 55.6 9.9 39.6 10.5 41 23 
Large  2316 60.0 10.0 70.0 9.2 41.3 10.5 42 29 
Rice          
Small  1804 30.0 11.3 41.3 10.1 35.8 9.9 93 38 
Medium  2030 45.0 10.6 55.6 9.3 36.3 9.9 100 55 
Large  2255 60.0 10.0 70.0 8.5 37.4 9.9 104 72 
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The macronutrient compositions of the standard test meals are presented in Table 5.3. As the 
proportion of pasta or rice within the meal increased, the percentage of total energy from 
carbohydrate increased and the percentage of total energy from protein and fat decreased.  
Table 5.3 Macronutrient composition of the standard test meals (% of total energy) 1 
 AvailCHO2 Protein Fat 
Pasta    
Small 43 35 21 
Medium 48 32 19 
Large 51 30 17 
Rice    
Small 44 34 20 
Medium 49 30 18 
Large 53 28 16 
1. Any small residual from available carbohydrate, protein and fat adding up to 100% is accounted for by the 
energy contribution from dietary fibre 
2. AvailCHO = CHO content – dietary fibre 
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5.3 Blood glucose concentration 
The mean fasting blood glucose concentrations and mean 90-minute blood glucose 
concentrations are presented in Table 5.4. As the amount of pasta or rice within the meal 
increased, so too did the mean 90-minute blood glucose concentrations (p=0.009 and p<0.001 
for trend respectively). The rice-based meals also produced higher 90-minute blood glucose 
concentrations than the pasta-based meals with this difference reaching significance for the 
small (p=0.028) and large (p=0.001) meals but not for the medium meals (p=0.068). 
Table 5.4 Mean (SD) fasting and 90-minute blood glucose concentrations 
 Fasting blood glucose 
concentration1 (mmol/L) 
90-minute blood glucose 
concentration (mmol/L) 
Pasta   
Small 4.5 (0.6) 5.0 (0.5) 
Medium 4.4 (0.4) 5.2 (0.6) 
Large 4.5 (0.6) 5.4 (0.7) 
Rice   
Small 4.7 (0.5) 5.4 (0.9) 
Medium 4.7 (0.5) 5.6 (1.0) 
Large 4.5 (0.5) 6.3 (1.2) 
1.Baseline blood glucose concentration 
5.4 Within group incremental area under the curve analysis 
Mean adjusted iAUC following the consumption of the different test meals and the within 
group difference in iAUC between these meals is presented in Table 5.5. For both the pasta 
and rice-based meals there was an increase in mean iAUC as the proportion of a starchy food 
within the meal increased (p<0.001 for trend).  
When comparing between the different meal proportions it was found that the glycaemic 
response to the small pasta meal was significantly less than the glycaemic response to the 
medium meal. There was however no significant difference between the medium and large 
pasta meals. The rice-based meals produced contrasting results, as there was no significant 
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difference between the glycaemic response to the medium and small meals whereas there was 
a significant difference between the medium and large meals.  
When comparing between the large and small meals, significant differences were found for 
both the pasta and rice-based meals (p<0.001). There was a 29% (13.3, 45.3) reduction in 
glycaemic response from the large to small pasta-based meals and 68% (46.0, 90.5) reduction 
from the large to small rice-based meals.  
Table 5.5 Mean iAUC and adjusted1 mean difference between the medium and small meal 
and the medium and large meal for both pasta and rice-based meals 
 Mean (S.D) of iAUC 
(mmol*min/L) 
Effect size (95% CI)  
(%) 
P-value 
Pasta    
       Small 92.9 (43.3) -24.7 (-40.7, -8.7) 0.002 
       Medium 117.6 (52.9) Reference  
       Large 122.2 (55.1) 4.6 (-11.4, 20.6) 0.573 
Rice    
       Small 128.6 (78.1) -11.4 (-33.7, 10.8) 0.314 
       Medium 140.1 (77.6) Reference  
       Large 196.9 (82.4) 56.8 (34.5, 79.1) <0.001 
1. Adjusted for order of intervention 
A comparison between the mean iAUCs of the different meal proportions is illustrated in 
Figures 5.2 and 5.3. No difference was observed between the pasta-based meals (Figure 5.2) 
during the first 30 minutes. However, there was some divergence between 30 and 45 minutes, 
with the small meal returning to baseline more quickly than the medium and large meals. The 
rice-based meals (Figure 5.3) showed greater variation. After the 15-minute time point the 
mean blood glucose concentrations diverged, with the large rice meal inducing a greater 
glycaemic response and returning to baseline less quickly than the medium and small meals.   
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Figure 5.2 Comparison of incremental area under the curve following the consumption of 
three pasta-based meals with different proportions of pasta and non-starchy vegetables 
 
Figure 5.3 Comparison of incremental area under the curve following the consumption of 



































































5.5 Between group incremental area under the curve analysis 
The adjusted mean difference in iAUC between the pasta and rice-based meals is presented in 
Table 5.6 and illustrated in Figure 5.4. While there was no significant difference in mean 
glycaemic response to the medium meals, both the small and large pasta-based meals induced 
a significantly lower glycaemic response compared to the rice-based meals. A sensitivity 
analysis was run that included whether the participant had a special meal (vegetarian, vegan 
or IBS) or not and this did not alter the results. 
Table 5.6 Adjusted1 mean effect size difference between the pasta and rice-based meals 
 Effect size (95% CI)2  
(%) 
P-value 
Small -27 (-46, -0.03) 0.048 
Medium -16 (-37, 13) 0.243 
Large -46 (-61, -25) <0.001 
1. Adjusted for order of intervention 
2. Results are presented as pasta compared to rice 
 
 
Figure 5.4 Comparison of incremental area under the curve between the pasta and rice-based 
meals for the different meal proportions 






























The aim of this study was to examine the glycaemic effect of varying the proportions of a 
starchy carbohydrate food (pasta or rice) and non-starchy vegetables within a meal. It was 
considered that as pasta and rice contain more available carbohydrate and have higher GIs 
than non-starchy vegetables, the substitution of a starchy food for non-starchy vegetables 
might attenuate glycaemic response. Results did indeed show a modest reduction in 
glycaemic response and 90-minute blood glucose concentration as more non-starchy and less 
starchy foods were included in the meal. For both the pasta and rice-based meals there was a 
significant difference in glycaemic response between the meals with the largest (60g available 
carbohydrate) and smallest (30g available carbohydrate) amount of starchy food. Using the 
medium meal (45g available carbohydrate from a starchy food) as a reference, there was no 
significant difference between the medium and large pasta-based meals, however there was a 
significant difference between the medium and small meals. For the rice-based meals there 
was a significant difference between the medium and large meals but no significant difference 
between the medium and small. A difference in iAUC of 57% was found between the 
medium and large rice-based meals with all other comparisons being comparatively smaller 
(<25%). Rice-based meals tended to induce a larger glycaemic response than pasta-based 
meals, although there was no significant difference in glycaemic response between the rice 
and pasta-based meals containing the medium amount of carbohydrate. Overall, there was a 
tendency for glycaemic response to increase with increasing amounts of pasta and rice. 
The positive association between glycaemic response and the increasing proportion of starchy 
food can be attributed to meal GL. A product of GI and the amount of carbohydrate within a 
meal (40), GL has consistently been found to be a reliable predictor of glycaemic response 
(16, 82, 83, 105, 133, 134). As pasta and rice have a higher GI (GI=43 and GI=115 
respectively) and carbohydrate content than non-starchy vegetables (GI=31) (17, 18, 94, 126), 
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replacing pasta and rice with non-starchy vegetables lessened meal GL (Table 5.2) and 
attenuated glycaemic response.   
Another factor that may have influenced the differences in glycaemic response among meals 
was the change in percentage energy from macronutrients. As illustrated in Table 5.3, the 
percentage of meal energy from carbohydrate increased as the proportion of starchy food 
increased which consequently decreased the percentage from protein and fat. In some studies, 
protein and fat have been found to attenuate glycaemic response (135, 136). Likely 
mechanisms for this include the stimulation of insulin secretion by protein (135) and the delay 
of gastric emptying by fat (137). However despite these percentages changing, the amount of 
protein within the meal differed only slightly and the amount of fat remained the same (Table 
5.2). It is therefore unclear whether changing the percentages rather than the amounts of 
protein or fat within the meal affected glycaemic response. It seems likely that the difference 
in glycaemic response between the meals is primarily due to the changes in available 
carbohydrate content. 
The significant difference in glycaemic response found between the medium and small pasta-
based meals and the non-significant difference between the medium and large, can likely be 
explained by the non-linear shape of the blood glucose concentration dose response curve. 
Several studies have shown that at lower intakes of carbohydrate the dose response in iAUC 
is approximately linear, while at higher intakes the rate of increase tends to decline and the 
curve flattens off (16, 82, 83, 105). Therefore, despite there being the same difference in 
available carbohydrate content between both the medium and small and medium and large 
meals, increasing the carbohydrate content of the meal at lower doses produced a greater 
difference in glycaemic response.  
For the rice-based meals glycaemic response appeared to be exaggerated for the meal 
containing the largest proportion of rice whereas it seemed relatively insensitive between the 
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meals that contained smaller rice proportions. An 11% difference between the medium and 
small meals and a 57% difference between the medium and large shows that the medium meal 
was not centrally located between these two. It is unclear what caused the marked increase in 
glycaemic response between the medium and large meals and whether it is due to an 
exaggeration of glycaemic response to the large meal or suppression in response to the 
medium meal. It remains to be seen whether these results would again be observed if the 
study were to be repeated. 
Although we did not measure the GI of the rice or pasta, or the GI of the meals, the larger 
glycaemic responses and 90-minute blood glucose concentrations from the rice-based meals 
compared to the pasta-based meals are likely due to the rice having a higher GI. However, the 
difference in glycaemic response to the pasta and rice-based meals was less exaggerated than 
the difference in estimated GI between these two foods (GI=43 and GI=115, respectively). 
There was also no significant difference in glycaemic response between the medium rice and 
pasta-based meals despite there being a considerable difference in the calculated GL of these 
meals. However, it is difficult to predict mixed meal GL (94) and this may account for these 
outcomes. 
The interaction between calculated meal GI and the proportions of starchy foods and non-
starchy vegetables is noteworthy. The GIs of the pasta-based meals were independent of the 
meal proportioning, attributed to the pasta and the non-starchy vegetables having similar GIs 
(GI=43 and GI=31, respectively). Whereas the rice had a much higher GI (GI=115) than the 
non-starchy vegetables, therefore, substituting non-starchy vegetables for rice increased meal 
GI (Table 5.2).  
The increasing trend we observed in 90-minute blood glucose concentration, as more pasta or 
rice and less non-starchy vegetables were included in the meal makes physiological sense. 
The increase in available carbohydrate content of the meals increased glycaemic response 
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therefore it took longer for the body to clear this extra glucose from the blood stream and 
return the concentration to baseline. A number of other studies have also found a dose 
response relationship between the amount of carbohydrate and 90-minute blood glucose 
concentrations (16, 83, 133, 134). In participants with T2DM, increasing the amount of 
carbohydrate induced even larger differences in 90-minute blood glucose concentration and it 
took longer for blood glucose concentration to return to baseline than in people with normal 
glucose tolerance (83, 133, 134). This suggests that if people with T2DM consumed the meal 
with the smallest proportion of pasta or rice compared to the largest proportion this may result 
in considerably less time spent in the hyperglycaemic range.  
6.1 Clinical implications 
The findings from this study suggest that for glycaemic outcomes people with normal glucose 
tolerance may not have to be too concerned about getting the proportions of starchy to non-
starchy foods within a meal exact. As despite significant differences being found, glycaemic 
response appears to be relatively insensitive between the different meal proportions. This is 
supported by literature finding no association between carbohydrate intake and the incidence 
of T2DM in a large European cohort (54). Although, data collected from this study by a 
fellow MDiet candidate found that the reduced energy density of the test meals lead to a 
decrease in total daily energy intake (138). Therefore, from an energy intake perspective, the 
general population should follow current advice to increase the proportion of non-starchy 
vegetables and decrease the proportion of starchy foods within their meal (20, 21). Non-
starchy vegetables are less energy dense than starchy carbohydrate foods therefore 
substituting these foods reduces the energy density of a meal (139-142), which may support 
weight management (143). 
For people with impaired glucose tolerance and T2DM the glycaemic findings may have 
more clinical relevance. In people with T2DM, the consumption of two meals of meat sauce 
 44 
and white rice with similar amounts of carbohydrate (45.8g and 65.8g) to the medium and 
large meals in our study induced large differences in glycaemic response between the two 
meals (285 and 453mmol/L*min, respectively) (134). Additionally, the glycaemic response to 
mixed meals was significantly greater in people with T2DM compared to people with normal 
glucose tolerance (28). This suggests that for people with T2DM decreasing the amount of 
available carbohydrate in the meal by substituting starchy foods for non-starchy vegetables 
may produce greater reductions in glycaemic response. As glycaemic response contributes to 
HbA1C (67-69) and to the development of macro- and micro-vascular complications as well as 
diabetes related mortality (6-12, 14), any attenuation in glycaemic response could lead to 
improved glycaemic control and risk reduction. Furthermore, separate components of this 
study found that satiety and energy intake following meal consumption did not vary between 
the different meal proportions (138). Recommending that people substitute starchy foods for 
non-starchy vegetables will therefore not lead to them feeling more hungry or cause them to 
consume more food at subsequent meals. Potential reductions in energy intake will also be 
beneficial for people with impaired glucose tolerance and T2DM as weight loss has been 
found to improve glycaemic control and to reduce the risk of developing diabetes related 
complications (144, 145). 
6.2 Strengths and limitations 
A considerable strength of this study was that the meal was practical, affordable and used 
foods that are commonly consumed. Furthermore, it was developed with reference to New 
Zealand food guidelines (21, 23), strengthening the applicability and relevance of results to 
dietetic practice. The methodology required participants to keep their food consumption and 
exercise prior to each testing session consistent to minimise intra-individual variation. 
Participant diet records, completed for the purpose of another MDiet candidate’s thesis, 
indicated compliance to this dietary requirement as no significant difference in intake was 
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observed across the three testing sessions (138). Other methodological strengths included 
standardised meal preparation and blood collection procedures and the crossover design, 
controlling for inter-individual variation in glycaemic response as a source of confounding.   
A limitation of this study was that participants with normal glucose tolerance were used rather 
than a study population of individuals with T2DM for whom clinical benefits may be more 
pronounced. However, it is likely that the glycaemic results have good generalisability to a 
diabetic population as studies have shown that relative glycaemic response (26-28) and the 
shape of the carbohydrate dose-response curve (16, 82, 83, 105, 133) are similar between 
individuals with and without T2DM. Often in glycaemic research, participants are instructed 
to finish a test food within a specified period of time; for example, GI methodology specifies 
12-15 min (33). The participants in our study were not required to do this and instead asked to 
complete the meal at their own pace. This may limit comparability between our data and other 
literature, however this was done deliberately as it was more representative of people’s eating 
behaviours and another MDiet candidate was timing the meal duration. Lastly, inter-
individual variation in glycaemic response may have influenced the reliability of comparisons 
between the pasta and rice-based meals, as the parallel aspect of this study design meant 
participants did not consume both of these starchy foods.  
6.3 Conclusion 
In a healthy young cohort of participants with normal glucose tolerance, glycaemic response 
was relatively insensitive to varying the proportions of starchy carbohydrate foods and non-
starchy vegetables within a meal. However, for both the pasta and rice-based meals 
differences in glycaemic response were found between the meals with the smallest and largest 
amount of starchy foods. This suggests that consuming starchy foods and non-starchy 
vegetables in proportions of approximately one quarter starchy foods and one half non-starchy 
vegetables ensures a relatively low glycaemic response and is in accordance with current 
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guidelines (20, 21). Although there was a considerable difference in GI between pasta and 
rice, the difference in glycaemic response between the pasta and rice-based meals was less 
exaggerated. Choosing to include pasta instead of rice within a meal will reduce glycaemic 
response to some extent, as will changing the proportions of starchy foods to non-starchy 
vegetables.   
Despite the argument that the relative glycaemic response should be comparable between 
people with and without T2DM, it is still recommended for future research that this study be 
conducted in a cohort of participants with T2DM. It would also be beneficial to undertake a 
long-term intervention study, as while some studies have asked people to increase their 
vegetable consumption (97, 98), none have asked people to directly substitute starchy foods 
for non-starchy vegetables within a meal. Assessing the practicality and acceptability of 
substituting these foods and measuring how HbA1C is affected would provide further 
information regarding the effectiveness of adopting this dietary strategy. 
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7 Application to dietetic practice 
The prevalence of obesity and diabetes is rapidly rising both in New Zealand (2, 146) and 
around the world (1, 147). Therefore, supporting individuals to make dietary changes for both 
weight reduction and improvements in glycaemic control is an increasingly important aspect 
of dietetic practice. 
In this study we found that the meal with the smallest proportion of pasta or rice and the 
largest proportion of non-starchy vegetables induced a reduction in glycaemic response 
compared to the meal containing the largest proportion of starchy food and the smallest 
proportion of non-starchy vegetables. Visually this preferred meal had one quarter of a plate 
starchy foods, one quarter protein and one half non-starchy vegetables, consistent with 
Diabetes New Zealand recommendations (21). Our data therefore provide evidence that 
strengthens the relevance and effectiveness of encouraging people to follow the healthy plate 
model (21). However, as results found glycaemic response to be relatively insensitive 
between the meals with the small and medium amount of starchy foods this indicates that it 
may not be critical for people to get the proportions of foods exact. Avoidance of the meal 
with the largest proportion of starchy food (half a plate) should still be recommended, 
however, some leniency with one quarter and one third of a plate may allow for personal 
preference. 
As well as encouraging people to follow the plate model, it will be important for dietitians to 
discuss the selection of an appropriate plate size, as this directly relates to the amount of food 
a person will consume. Matching a person’s plate size and therefore meal size to their lifestyle 
and clinical goals will ensure that the plate model guidelines are applicable to the majority of 
the population. 
Advising individuals to follow the plate model will likely be a simpler strategy to implement 
than adopting a vastly different diet, which may improve long-term compliance to dietary 
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changes. Furthermore, if people are consuming appropriate meal sizes another positive aspect 
of changing the proportions of meal components is that it will not alter the total quantity of 
the meal and therefore the meal will not appear smaller.  
In our study the recommended one quarter of a plate of starchy foods equated to 30g available 
carbohydrate, however the total available carbohydrate content of the meal was much higher 
than this at around 50g, due to the additional carbohydrate provided by the vegetables and 
sauce. It is therefore necessary for dietitians to educate people with T2DM about the 
carbohydrate contribution from other aspects of a meal. Limiting the proportion of starchy 
foods to around one quarter of a plate will not be as effective at reducing glycaemic response 
if the remaining components of the meal include sauces and ingredients high in carbohydrate.  
Advice to consume pasta instead of rice due to the lower glycaemic response that pasta 
induces should be given on an individual basis and not used as a blanket guideline. Cultural, 
ethnic and taste preferences as well as gluten allergies or intolerances may limit the 
practicality of this advice for some individuals.  
The results from our study underline the usefulness of recommending a visual model for meal 
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Appendix A: Ethics proposal 
 
UNIVERSITY OF OTAGO HUMAN ETHICS COMMITTEE 
APPLICATION FORM: CATEGORY A 
Form updated: Feb 2016 
 
 
1. University of Otago staff member responsible for project:  
Surname First Name Title (Dr) 
 





3. Contact details of staff member responsible (always include your email address): 
bernard.venn@otago.ac.nz 
Tel 03 479 5068 
 
4. Title of project: HUNT311 clinical nutritional laboratory; a repeated teaching activity 
 
5. Indicate project type and names of other investigators and students:  
Staff Co-investigators   Names:  
 
Student Researchers         Names:  
 
Level of Study (PhD, Masters, Hons):  
 





Kate Martin  
Eilis Woodward  





6. Is this a repeated class teaching activity? (Delete answer that does not apply) 
 YES 
 If YES and this application is to continue a previously approved repeated class  
teaching activity, provide Reference Number: 13/022 
 
7. Fast-Track procedure (Delete answer that does not apply) 
 Do you request fast-track consideration? (See ‘Filling Out Your Human  
Ethics Application’) 
NO 
 If YES, provide a robust justification on the need for urgency: 
 
 
8. When will recruitment and data collection commence? 
 February 2016 
 
When will data collection be completed? 
April 2016 
 
9. Funding of project 
 Is the project to be funded by an external grant? 
 NO 
If YES, specify who is funding the project: 
 
If commercial use will be made of the data, will potential participants be made aware  
of this before they agree to participate? If not, explain:  





10. Brief description in lay terms of the purpose of the project (approx. 75 words): 
The purpose of the HUNT311 laboratories is for students to experience participation 
in a clinical nutritional trial. Measured outcomes will be changes in blood glucose and 
feelings of hunger in response to consuming various carbohydrate containing foods. 
Speed of eating will be timed. The laboratory will be a source of individual and group 
data to be used in a class assignment with potential for publication using anonymous 
group data.  
 
11. Aim and description of project  
The aim of this laboratory is to test glycaemic, satiating and speed of eating outcomes 
to cooked meals comprising meat, vegetables and carbohydrate in various proportions. 
This information will be used by HUNT311 students as a learning exercise and in the 
writing of his or her assignment.  
 
12. Researcher/instructor experience and qualifications in this research area  
Dr. Venn is experienced in conducting research trials involving human participants. 
Testing will be carried out according to our standard procedure in the Department of 
Human Nutrition Undergraduate Laboratories.  
 
13. Participants   
13(a) Population from which participants are drawn: Human Nutrition students 
13(b) Inclusion and exclusion criteria:  
Inclusion: men and women in the age range of 18 – 60 y, inclusive. 
13(c) Estimated number of participants: All HUNT311 students 
13(d) Age range of participants: 18-60y 
13(e) Method of recruitment: Recruitment will be by invitation to the 
students by email and in class at the University of Otago. 
13(f) Specify and justify any payment or reward to be offered  
 No payment or reward 
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14. Methods and Procedures:  
The purpose and scope of the laboratory will be discussed in class. An Information 
Sheet (attached) will be given to students and teaching and research staff will be 
available to answer questions regarding the study. If students are willing to continue, a 
consent form (attached) will be given to them. Participants will have their height and 
weight measured in a screened-off area to ensure the participants privacy. A 
questionnaire will be administered to ensure that eligibility criteria are met and for 
collection of demographic data. Test foods will be provided to participants. In 2016, 
the foods will be meals prepared by the MDiet candidates. 
 
For measuring blood glucose, capillary blood is collected by finger pricking using a 
sterilised disposable lancet. During each test, a series of eight blood samples are 
collected over a period of three hours following the consumption of the food. Each 
student will test three meals, each on a separate non-consecutive day. The Department 
of Human Nutrition will use trained personnel to do the finger pricking. Students will 
attend the laboratory after fasting for at least two and a half hours. On each of the test 
days, a finger-prick blood sample will be taken as a baseline blood glucose 
concentration. This method of collecting blood for analysis causes minimal discomfort 
to the participant. Blood glucose concentrations will be determined from a drop of 
blood using a Hemocue Glucose 201 Analyzer. Following this, a test meal will be 
consumed over a fifteen to twenty minute period and a series of five more finger-
pricks will be undertaken at 15, 30, 45, 60 and 90 min. In the event of an abnormal 
result, a repeat fingerprick may be required. Adhesive plasters will be provided to hold 
in place a cotton wool swab covering the small incision. The total volume of blood 
extracted from the finger-pricks will be less than two millilitres. There is no excess 
blood for disposal. During this laboratory, students will also be given a set of 
questions regarding how hungry they feel as a measure of satiety.  
 
15. Compliance with The Privacy Act 1993 and the Health Information Privacy Code 
1994 imposes strict requirements concerning the collection, use and disclosure of 
personal information.  The questions below allow the Committee to assess 
compliance. 
15(a) Are you collecting and storing personal information (e.g.name, contact details, 
designation, position etc) directly from the individual concerned that could 
identify the individual? (Delete the answer that does not apply.) 
YES   
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15(b) Are you collecting information about individuals from another source?  
NO 
If YES, explain: 
 
15(c) Collecting Personal Information (Delete the answer that does not apply): 
• Will you be collecting personal information (e.g. name, contact details, 
position, company, anything that could identify the individual)? 
 YES  
• Will you inform participants of the purpose for which you are collecting the 
information and the uses you propose to make of it? 
 YES  
• Will you inform participants of who will receive the information? 
 YES  
• Will you inform participants of the consequences, if any, of not supplying the 
information? 
 YES  
• Will you inform participants of their rights of access to and correction of 
personal information? 
 YES  
 Where the answer is YES, make sure the information is included in the Information 
Sheet for Participants. 
 If you are NOT informing them of the points above, please explain why: 
 
15(d) Outline your data storage, security procedures and length of time data will 
be kept  
The information will remain confidential to the study investigators. Paper 
copies will be kept in a lockable office and electronic data stored on 
departmental computers in password protected files. The results of this study 
may be published but no individual's identity will be revealed. At the end of the 
project any personal information will be destroyed immediately except that, as 
required by the University's research policy, any raw data on which the results 
of the project depend will be retained in secure storage for five years, after 
which it will be destroyed.  
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15(e) Who will have access to personal information, under what conditions, and 
subject to what safeguards? If you are obtaining information from another 
source, include details of how this will be accessed and include written permission 
if appropriate.  Will participants have access to the information they have 
provided? 
Only Dr Bemard Venn will have permanent access to the personal information. Paper 
copies will be stored in Dr Venn's University of Otago office and any information 
transferred into digital form will be stored on Dr Venn's University computer. If a 
nominated postgraduate student enters data, this will only be done on a desktop 
university password-protected computer. At the completion of data entry, the student 
will be asked to transfer the electronic file to Dr Bemard Venn and to delete the file 
from the student computer. 
Statistical analysis will be done using anonymous data. 
 
15(f) Do you intend to publish any personal information they have provided? 
 NO 
 If YES, specify in what form you intend to do this: 
 
15(g) Do you propose to collect demographic information to describe your 
sample? For example: gender, age, ethnicity, education level, etc. 
Yes 
 
15 (h) Have you, or will you, undertake Māori consultation? Choose one of the 
options below, and delete the option that does not apply: 
 (Refer to http://www.otago.ac.nz/research/maoriconsultation/index.html). 
NO If not, provide a brief outline of your reasons (e.g. the research is being 
undertaken overseas): 
YES We have completed the University of Otago online Māori consultation form 
attached (pages 14-15). It is scheduled for discussion at the Ngāi Tahu 
Research Consultation Committee meeting 18th Nov. 
16. Does the research or teaching project involve any form of deception?   
NO 
If yes, explain all debriefing procedures: 
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17. Disclose and discuss any potential problems or ethical considerations: (For 
example: medical or legal problems, issues with disclosure, conflict of interest, safety of the 
researcher, etc.  Note: if the student researcher will be travelling overseas to undertake the 
research, refer to item 12 of the Filling Out Your Human Ethics Application document.  
Please note that approval from the Human Ethics Committee does not override the University 
of Otago’s Field Policy and Travel Policy, which must be complied with.) 
 
This is a repeated teaching activity and research students may be involved in data collection 
and analysis from year to year. The research students will only work with data with the 
University of Otago student ID as an identifier, rather than student names.  
There may be some discomfort from finger pricking 
 
 
18. *Applicant's Signature:   .............................................................................   
 Name (please print): ………………………………………………………. 
 Date:  ................................ 
 *The signatory should be the staff member detailed at Question 1. 
 
 
19. Departmental approval:  I have read this application and believe it to be valid 
research and ethically sound.  I approve the research design.  The Research proposed in this 
application is compatible with the University of Otago policies and I give my consent for the 
application to be forwarded to the University of Otago Human Ethics Committee with my 
recommendation that it be approved. 
Signature of **Head of Department: .......................................................................... 
 Name of HOD (please print): ………………………………………………………. 
  Date: ..................................................... 
**Where the Head of Department is also the Applicant, then an appropriate senior staff 
member must sign on behalf of the Department or School. 
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Appendix B: Ethical approval letter 
Note: This is a repeated teaching activity; therefore this ethical approval letter from 











Tuesday, 18 November 2014. 
Dr Bernard Venn, 






HUNT311 clinical nutritional laboratory; a repeated teaching activity 
7KH1JƗL7DKX5HVHDUch Consultation Committee (the committee) met on Tuesday, 18 
November 2014 to discuss your research proposition. 
By way of introduction, this response from The Committee is provided as part of the 





process is part of a number of requirements for researchers to undertake and does not cover 
other issues relating to ethics, including methodology they are separate requirements with 
other committees, for example the Human Ethics Committee, etc. 
:LWKLQWKHFRQWH[WRIWKH3ROLF\IRU5HVHDUFK&RQVXOWDWLRQZLWK0ƗRULWKH&RPPLWWHHEDVH
consultation on that defined by Justice McGechan: 
Ǝ&RQVXOWDWLRQGRHVQRWPHDQQHJRWLDWLRQRUDJUHHPHQW,WPHDQVVHWWLQJRXWDSURSRVDOQRW
fully decided upon; adequately informing a party about relevant information upon which the 
proposal is based; listening to what the others have to say with an open mind (in that there is 
room to be persuaded against the proposal); undertaking that task in a genuine and not 
FRVPHWLFPDQQHU5HDFKLQJDGHFLVLRQWKDWPD\RUPD\QRWDOWHUWKHRULJLQDOSURSRVDOƎ 
The Committee considers the research to be of iPSRUWDQFHWR0ƗRULKHDOWK 
 
The Committee notes this is a class laboratory exercise but also notes it is dealing with some 
important aspects for 0ƗRUL health. The Committee suggests that 0ƗRUL health issues are 
outlined as part of this class to discuss important health disparities. 
We wish you every success in your research and the committee also requests a copy of the 
research findings. 
This letter of suggestion, recommendation and advice is current for an 18 month period from 




















Appendix D: Participant information sheet 
HUNT311 clinical nutritional laboratory; a repeated teaching activity  
INFORMATION SHEET FOR PARTICIPANTS  
Thank you for showing an interest in this project. Please read this information sheet carefully 
before deciding whether or not to participate. If you decide to participate we thank you. If you 
decide not to take part there will be no disadvantage to you and we thank you for considering our 
request.  
What is the Aim of the Project?  
The aim of this study is to test the glycaemic and satiating properties of three meals. This requires 
attending the laboratory on three occasions. You and other HUNT311 students will use the 
information in the writing of a HUNT311 assignment. If you choose not to participate, you will 
still be required to attend the laboratory to observe and data will be provided to you; the 
assessment of your assignment will in no way be affected.  
What Type of Participants are Being Sought?  
HUNT311 students who are willing to participate. If you have special dietary needs please let us 
know. The meal will be gluten-free, dairy-free, and nut-free. A vegetarian option is available.   
What will Participants be Asked to Do?  
You will be asked to attend the Department of Human Nutrition Undergraduate Laboratory on 
three occasions, separated by one or two weeks apart. If eligibility criteria are met, you will be 
asked to read and sign a consent form, we will collect some personal information from you 
comprising demographics, height and weight. Following this, the first test will be conducted. 
Testing is conducted at lunchtime, you will be streamed to arrive at the laboratory either at 
11:50am, or at 1:15pm. You will be asked not to eat or drink for two and a half hours before the 
start time  (ie; for those people attending the 11:50 lab, please do not eat or drink after 9:15am: for 
those attending the 1:15pm lab, please do not eat or drink after 10:30 am). If you have eaten 
within this period of time you will be turned away and asked to reschedule your lab. Note: 
no sugar-sweetened chewing gum, you may drink water up until 30 min before the start time but 
please do not drink too much water as you are required to eat a full sized meal. 
 
 If you walk or cycle to the laboratory please do so slowly so as not to elevate your heart rate and 
blood glucose. On arrival a finger-prick blood sample will be taken in the fasting state using a 
single-use disposable lancet designed to minimize discomfort. You will then be given a meal. 
After this, additional finger-prick blood samples will be taken at 15, 30, 45, 60 and 90 min. The 
fingerpricks may cause some discomfort. In the event of an abnormal result, a repeat finger-prick 
may be required. The total volume of blood collected will amount to less than half a teaspoon. 
During this time we would like you to remain seated in the room with the exception of toilet visits 




What Data or Information will be Collected and What Use will be Made of it?  
For the main laboratory exercise we will collect data on your age, ethnicity, smoking habits and 
gender and we will be measuring your height and weight. The purpose of collecting this 
information is to describe the overall characteristics of the study population. From your blood 
samples we will be testing glucose concentration. Personal information will remain confidential to 
the study investigators. Paper copies will be kept in a lockable office and electronic data stored on 
a departmental computer. The results of the project will be pooled and may be published and 
available in the University of Otago Library (Dunedin, New Zealand) but every attempt will be 
made to preserve your anonymity. The data and samples collected will be securely stored in such 
a way that only those mentioned below will be able to gain access to it. Data and samples 
obtained as a result of the research will be retained for at least 5 years in secure storage. Any 
personal information held on the participants such as contact details may be destroyed at the 
completion of the research even though the data and samples derived from the research will, in 
most cases, be kept for much longer or possibly indefinitely. If you choose not to supply 
information this may exclude you from taking part in the study. You have rights of access to the 
personal information that you have given to us and you may correct or change this information.  
Testing blood glucose has the potential to reveal whether a person has diabetes or is at risk of 
pre-diabetes. If elevated blood glucose concentrations are found, you will be advised to make 
an appointment with student health or with your general practitioner.  
Can Participants Change their Mind and Withdraw from the Project?  
You may withdraw from participation in the project at any time and without any disadvantage to 
yourself or to your HUNT311 assessment of any kind.  
What if Participants have any Questions?  
If you have any questions about our project, either now or in the future, please contact - 
Liz Williams; email e.williams@otago.ac.nz 
Dr Bernard Venn; email bernard.venn@otago.ac.nz 
Telephone: 03 479 5068  
This study has been approved by the University of Otago Human Ethics Committee. If you have any 
concerns about the ethical conduct of the research you may contact the Committee through the Human 
Ethics Committee Administrator (ph 03 479 8256). Any issues you raise will be treated in confidence 
and investigated and you will be informed of the outcome. 
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Appendix E: Participant consent form 
HUNT311 clinical nutritional laboratory; a repeated teaching activity  
 
CONSENT FORM FOR PARTICIPANTS 
 
I have read the Information Sheet and understand the procedures. All my questions have  
been answered to my satisfaction. I understand that I am free to request further information  
at any stage.  
 
I know that: 
1. My participation in the project is entirely voluntary;  
2. I am free to withdraw from the project at any time without any disadvantage to myself or to 
my HUNT311 assessment;  
3. Personal identifying information will be destroyed at the conclusion of the project but any raw 
data on which the results of the project depend will be retained in secure storage for at least 
five years;  
4. Fingerprick blood sampling may cause some discomfort.  
5. The results of the project may be published and will be available in the University of Otago 
Library (Dunedin, New Zealand), but every attempt will be made to preserve my anonymity 
 
I consent to attending the laboratory on three days following a two and a half hour fast, having height 
and weight taken, consuming the meals and providing six blood samples obtained by finger pricking 
over two hours on each test day 
 




Name ........................................... Signature................................................. . Date ........................ . 
This study has been approved by the University of Otago Human Ethics Committee. If you have 
any concerns about the ethical conduct of the research you may contact the Committee through 
the Human Ethics Committee Administrator (ph 03 479 8256). Any issues you raise will be 
treated in confidence and investigated and you will be informed of the outcome. 
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Appendix F: Clinical trial registration 
 
LOGINCREATE ACCOUNT
MY TRIALSREGISTER TRIALFAQsHINTS AND TIPSDEFINITIONS
VIEW TRIAL AT REGISTRATION VIEW HISTORY
< BACK
Trial Review
Trial registered on ANZCTR
Trial ID ACTRN12616000716460
Ethics application status Approved
Date submitted 20/05/2016
Date registered 30/05/2016
Type of registration Retrospectively registered
Titles & IDs
Public title Glycaemic response to varying the proportions of carbohydrate and vegetables within a meal
Scienti!c title The e!ect of consuming meals with di!erent proportions of carbohydrate and vegetables by healthy
young adults on glycaemic response
Secondary ID [1] None
Universal Trial Number (UTN) U1111-1183-4253
Trial acronym
Health condition
Health condition(s) or problem(s) studied:
Postprandial glycaemia
Condition category Condition code
Diet and Nutrition Other diet and nutrition disorders
Metabolic and Endocrine Normal metabolism and endocrine development and function
Intervention/exposure
Study type Interventional
Description of intervention(s) /
exposure
This is a dietary intervention study in which healthy young adults will consume test meals with di!ering
proportions of carbohydrate (rice or pasta based meals) and non-starchy vegetables. Half of the
participants will be randomised to receive pasta-based meals and the other half to receive rice-based
meals. Within each intervention group participants will consume a meal with 30g and 60g of available
carbohydrate at two separate testing sessions. The amount of rice and pasta corresponding to the 30 and
60g available carbohydrate will be 100 and 200g, respectively. The amount of non-starchy vegetables on
the plate will be 250 and 150g, respectively (ie: a gram for gram replacement of rice or pasta with
non-starchy vegetables). The amount of mince and sauce will be constant at 200g. The total weight of
each meal will be 550g. Participant’s blood glucose concentration will be measured prior to consuming the
meal and then at 15, 30, 45, 60 and 90 minutes after this time point. The order of test meal consumption
will be randomised. The meals will be served hot (>65 deg C). Participants will consume the meals with
instruction to "nish all of the food on the plate in their own time while under supervision at the study site.
The washout period between successive lunch meals will be one week.
Intervention code [1] Lifestyle
Intervention code [2] Treatment: Other
Intervention code [3] Prevention
Comparator / control treatment Participants will consume a third test meal with 45g of available carbohydrate at a separate testing session.
This will act as the control as it is the amount of available carbohydrate that Diabetes New Zealand
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recommends individuals with type 2 diabetes mellitus to consume within a starchy food at a main meal.
The meals with 30g and 60g of available carbohydrate represent a one serving (15g available
carbohydrate) di!erence from this control meal.
Control group Active
Outcomes
Primary outcome [1] Blood glucose concentration will be measured on "ngerprick samples using a Hemocue glucose analyser
at each timepoint. The blood glucose data will be plotted and incremental area-under-the-curve will be
calculated using the trapezoidal rule.
Timepoint [1] Baseline and thereafter at 15, 30, 45, 60 and 90 min following consumption of test meal
Secondary outcome [1] Blood glucose concentration at 90 min
Timepoint [1] 90 min following consumption of the test meal
Eligibility
Key inclusion criteria Healthy university students
Minimum age 18 Years
Maximum age 60 Years




Key exclusion criteria A dietary requirement that we cannot cater to. There will be no other exclusion criteria.
Study design
Purpose of the study Prevention
Allocation to intervention Randomised controlled trial
Procedure for enrolling a subject
and allocating the treatment
(allocation concealment
procedures)
Participants will be randomly assigned to receive either rice or pasta-based meals and to the order they
will receive the meals. The person who will determine if a subject is eligible for inclusion in the trial will be
unaware, when this decision is made, to which group the subject will be allocated. Randomisation will be
performed by the department statistician, the researchers will remain unaware of allocations until the
laboratory phase.
Methods used to generate the
sequence in which subjects will
be randomised (sequence
generation)
Males will be block randomised to ensure equal sex distribution between the two groups, controlling for
any potential sex variability in glycaemic response. Simple randomisation will be used for order treatment
and all randomisation will be done using Stata statistical analysis software.
Masking / blinding Open (masking not used)
Who is / are masked / blinded?
Intervention assignment Crossover
Other design features Crossover refers to the di!erent proportions of starchy carbohydrate and vegetables on the plate, each
person consumes three meals in randomised order containing 30, 45 and 60g starchy carbohydrate. There
is also a parallel component to the study in which participants will be randomised to the starchy
carbohydrate of either rice or pasta-based meals.
Phase Not Applicable
Type of endpoint(s) E#cacy
Recruitment
Anticipated date of !rst
participant enrolment
Actual date of !rst participant
enrolment
2/03/2016
Anticipated date last participant
enrolled
Actual date last participant
enrolled
9/03/2016
Anticipated date of last data
collection
Actual date of last data
collection
Target sample size 68





Country [1] New Zealand
State/province [1] Otago
Funding & Sponsors
Funding source category [1] University
Name [1] University of Otago




Country [1] New Zealand
Primary sponsor type University
Name University of Otago










Ethics application status Approved
Ethics committee name [1] University of Otago Human Ethics Committee
Ethics committee address [1] PO Box 56
Dunedin
9054
Ethics committee country [1] New Zealand
Date submitted for ethics
approval [1]
02/02/2015
Approval date [1] 16/02/2015
Ethics approval number [1] 14/204
Summary
Brief summary A randomised controlled crossover trial in which participant’s blood glucose concentrations will be
measured following the consumption of three test meals. Each meal will have di!erent proportions of
carbohydrate and non-starchy vegetables. The amount of starchy carbohydrate on the plate will be 30, 45
and 60g. The comparator will be the meal containing 45g starchy carbohydrate.
There will also be a parallel design in which the the starchy carbohydrate will be rice or pasta. Participants
will be randomised to either rice or pasta-based meals.
Trial website





Name Dr Bernard Venn
Address University of Otago




















How to register a trial




Search for a trial
Find a trial
How to search
How to get involved
Major funders
Privacy | Disclaimer




Contact person for public queries
Name Dr Bernard Venn
Address University of Otago








Contact person for scienti!c queries
Name Dr Bernard Venn
Address University of Otago








Copyright © Australian New Zealand Clinical Trials Registry. All rights reserved.
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Appendix G: Calculation of the quantity of the starchy food in 
each test meal 
Pasta 
• 73.8g CHO / 100g dried pasta (from product Nutrition Information Panel) 
= 0.738g CHO per 1g dried pasta 
• 500g dried pasta → 1250g cooked pasta (from experimentation) 
1250g / 500g = 2.5g cooked pasta per 1g dried pasta 
• 0.738g CHO / 2.5 = 0.2952g CHO per 1g cooked pasta 
• 30g available CHO / 0.2952 = 102g pasta (practically rounded to 100g)  
• 45g available CHO / 0.2952 = 152g pasta (practically rounded to 150g)  
• 60g available CHO / 0.2952 = 203g pasta (practically rounded to 200g) 
 
Rice 
• 79g CHO / 100g raw rice (from product Nutrition Information Panel) 
= 0.79g CHO per 1g raw rice 
• 500g raw rice → 1300g cooked rice (from experimentation) 
1300g / 500g = 2.6g cooked rice per 1g raw rice 
• 0.79g CHO / 2.6 = 0.3039g CHO per 1g cooked rice 
• 30g available CHO / 0.3039 = 99g rice (practically rounded to 100g) 
• 45g available CHO / 0.3039 = 148g rice (practically rounded to 150g) 
• 60g available CHO / 0.3039 = 197g rice (practically rounded to 200g) 
  
 79 





















#1 10.3 10.3 10.2 10.3 10.3 10.3 10.2 10.3 10.3 
#2 10.1 10.2 10.1 10.1 10.2 10.2 10.1 10.2 10.2 
#3 10.1 10.1 10.1 10.1 10.1 10.1 10.1 10.1 10.1 
#4 10.0 10.0 10.1 10.0 10.0 10.0 10.0 10.0 10.0 
#5 10.5 10.5 10.6 10.5 10.6 10.6 10.5 10.5 10.5 
1. All values are in mmol/L 
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Appendix J: Research assistant blood glucose recording sheet 
Recorders name: 
Date/ lab number: 
Time: 11:50am or 1pm (circle 
one) 
 











       




      
15 
minutes 




      
30 
minutes 




      
45 
minutes 




      
60 
minutes 




      
90 
minutes 


























New'Zealander' ' ' Samoan'
Tongan' ' ' ' Chinese'





Samoan' ' ' ' Cook'Island'Maori'
Tongan' ' ' ' Niuean'




Yes' ' ' ' ' No'
'
Have'you'ever'been'a'regular'smoker'of'one'or'more'cigarettes'a'day?'(please'circle)'




Not'at'all' ' 1H2' ' 3H4' ' 5H6' ' 7+'
'
On'average'how'long'do'you'exercise'for'at'a'time?'(Please'circle)'












Appendix L: Preparation methods for special meals 
Vegetarian mince alternative: 
The vegetarian mince alternative (Quorn, Marlow Foods Ltd; Australia) was prepared using 
the same cooking method as the regular mince. For every 1kg of raw vegetarian mince 
alternative, 1kg of pasta sauce (Extra Bolognaise Pasta Sauce, Dolmio®, Mars Food; 
Australia) and 2 teaspoons of canola oil (Sunfield Oils, Tasti Products Ltd, Auckland; New 
Zealand) were used. 
IBS meals: 
Raw premium beef mince (New World, Dunedin; New Zealand) was prepared using the same 
cooking method as the regular mince. Instead of the regular pasta sauce a pasta sauce free of 
onions (Passata Cooking Sauce Italian Herbs and Spice, Leggo’s, Simplot Australia Pty Ltd; 
Australia) was used with a ratio of 700g raw mince: 700g pasta sauce: 1.5 teaspoons canola 
oil (Sunfield Oils, Tasti Products Ltd, Auckland; New Zealand). The vegetables (International 
Stir-fry Mix, Wattie’s®, Heinz Wattie’s Ltd, New Zealand) were prepared using the same 
cooking method as the standard vegetables. 
Vegan protein alternative: 
Strained canned chickpeas (Chickpeas in spring water, Wattie’s®, Heinz Wattie’s Ltd, New 
Zealand) were placed onto the plate and the pasta sauce (Extra Bolognaise Pasta Sauce, 





Appendix M: Glycaemic index and glycaemic load calculation 
Meal type GI1 AvailCHO (g) GL2, 3  
Standard and vegetarian    
Small pasta (total) 40 41.3 16.7 
Penne pasta 43 30.0 12.9 
Stir fry vegetables 31 3.3 1.0 
Pasta sauce 35 8.0 2.8 
    
Medium pasta (total) 41 55.6 23.0 
Penne pasta 43 45.0 19.4 
Stir fry vegetables 31 2.6 0.8 
Pasta sauce 35 8.0 2.8 
    
Large pasta (total) 42 70 29.2 
Penne pasta 43 60.0 25.8 
Stir fry vegetables 31 2.0 0.6 
Pasta sauce 35 8.0 2.8 
    
Small rice (total) 93 41.3 38.3 
Jasmine rice 115 30.0 34.5 
Stir fry vegetables 31 3.3 1.0 
Pasta sauce 35 8.0 2.8 
    
Medium rice (total) 100 55.6 55.4 
Jasmine rice 115 45.0 51.8 
Stir fry vegetables 31 2.6 0.8 
Pasta sauce 35 8.0 2.8 
    
Large rice (total) 104 70 72.4 
Jasmine rice 115 60.0 69 
Stir fry vegetables 31 2.0 0.6 
Pasta sauce 35 8.0 2.8 
    
Vegan    
Small rice (total) 79 55.5 43.7 
Jasmine rice 115 30.0 34.5 
Stir fry vegetables 31 3.3 1.0 
Pasta sauce 35 10.0 3.5 
Chickpeas 38 12.2 4.6 
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Meal type GI1 AvailCHO (g) GL2, 3  
Vegan    
Medium rice (total) 87 69.8 60.7 
Jasmine rice 115 45.0 51.8 
Stir fry vegetables 31 2.6 0.8 
Pasta sauce 35 10.0 3.5 
Chickpeas 38 12.2 4.6 
    
Large rice (total) 92 84.2 77.8 
Jasmine rice 115 60.0 69.0 
Stir fry vegetables 31 2.0 0.6 
Pasta sauce 35 10.0 3.5 
Chickpeas 38 12.2 4.6 
    
IBS    
Small rice (total) 107 33.4 35.7 
Jasmine rice 115 30.0 34.5 
Stir fry vegetables 31 0.5 0.2 
Pasta sauce 35 2.9 1.0 
    
Medium rice (total) 110 48.3 52.9 
Jasmine rice 115 45.0 51.8 
Stir fry vegetables 31 0.4 0.1 
Pasta sauce 35 2.9 1.0 
    
Large rice (total) 111 63.2 70.1 
Jasmine rice 115 60.0 69.0 
Stir fry vegetables 31 0.3 0.1 
Pasta sauce 35 2.9 1.0 
1. Meal GI = {(GIFood A x AvailCHOFood A (g)) + (GIFood B x AvailCHOFood B (g)) +…} /AvailCHOMeal (g) 
2. GL = (GI x AvailCHO (g)) / 100 





Appendix N: Nutritional composition of the special meals 
1. All values are presented per meal 
2.  Total cooked weight was 550g for all vegetarian and IBS meals and 575g for all vegan meals  




Meal type1, 2 Energy 
(kJ) 











& sauce  
Total 
Vegetarian          
Pasta          
Small  1590 30.0 21.7 51.7 28.5 29.2 6.6 42 17 
Medium  1832 45.0 19.4 64.4 27.8 30.8 6.6 42 23 
Large  2074 60.0 16.5 76.5 27.2 32.5 6.6 42 30 
Rice          
Small  1562 30.0 22.8 52.8 28.2 27.0 6.6 94 39 
Medium  1789 45.0 20.5 65.5 27.3 27.5 6.6 100 56 
Large  2013 60.0 18.1 78.1 26.5 28.6 6.6 104 73 
Vegan          
Rice          
Small  1541 30.0 11.5 61.5 18.2 16.1 6.9 80 44 
Medium  1771 45.0 19.2 74.2 17.4 16.7 6.9 88 61 
Large  1995 60.0 26.8 86.8 16.6 17.3 6.9 93 78 
IBS          
Rice          
Small  1716 30.0 17.3 47.3 9.7 35.2 9.4 107 36 
Medium  1947 45.0 15.0 60.0 8.8 35.8 9.4 110 53 
Large  2178 60.0 13.2 73.2 7.9 36.3 9.4 111 70 
